Ascentage Pharma Group International Unsponsored ADR Financial Overview
Ascentage Pharma Group International Unsponsored ADR's market cap is currently $2.60B. The company's EPS TTM is $-0.97; its P/E ratio is -13.85; Ascentage Pharma Group International Unsponsored ADR is scheduled to report earnings on August 20, 2025, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.
